Last updated: August 15, 2023
Sponsor: University of South Florida
Overall Status: Active - Recruiting
Phase
N/A
Condition
Panic Disorders
Depression
Mood Disorders
Treatment
Therapy + Adhere.ly
Therapy
Clinical Study ID
NCT05866185
002555
5R41MH126734-02
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria: Providers:
- English-speaking
- Mental health providers who have obtained at least a master's degree in social work,counseling, clinical psychology, or related field
- Carry active mental health treatment caseloads in the U.S.
- Have a laptop, tablet, or smartphone with internet access Clients:
- English-speaking
- Treatment-seeking adults ≥18 year
- Clinically elevated anxiety and depression as indicated by a score ≥10 on the GAD-7and/or PHQ-8
- Have a laptop, tablet, or smartphone with internet access
Exclusion
Exclusion Criteria: Client with self-reported:
- Active psychotic symptoms (e.g., hallucinations, delusions)
- Significant cognitive disability, developmental delays, or pervasive developmentaldisorder.
Study Design
Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Therapy + Adhere.ly
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
May 31, 2024
Connect with a study center
University of South Florida
Tampa, Florida 33613
United StatesActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.